12-123744882-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_012463.4(ATP6V0A2):​c.1515T>C​(p.Asn505Asn) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.651 in 1,613,844 control chromosomes in the GnomAD database, including 347,608 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.71 ( 39330 hom., cov: 32)
Exomes 𝑓: 0.65 ( 308278 hom. )

Consequence

ATP6V0A2
NM_012463.4 splice_region, synonymous

Scores

2
Splicing: ADA: 0.00005240
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -1.06

Publications

28 publications found
Variant links:
Genes affected
ATP6V0A2 (HGNC:18481): (ATPase H+ transporting V0 subunit a2) The protein encoded by this gene is a subunit of the vacuolar ATPase (v-ATPase), an heteromultimeric enzyme that is present in intracellular vesicles and in the plasma membrane of specialized cells, and which is essential for the acidification of diverse cellular components. V-ATPase is comprised of a membrane peripheral V(1) domain for ATP hydrolysis, and an integral membrane V(0) domain for proton translocation. The subunit encoded by this gene is a component of the V(0) domain. Mutations in this gene are a cause of both cutis laxa type II and wrinkly skin syndrome. [provided by RefSeq, Jul 2009]
ATP6V0A2 Gene-Disease associations (from GenCC):
  • wrinkly skin syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Genomics England PanelApp
  • autosomal recessive cutis laxa type 2, classic type
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Genomics England PanelApp, Orphanet
  • autosomal recessive cutis laxa type 2A
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 12-123744882-T-C is Benign according to our data. Variant chr12-123744882-T-C is described in ClinVar as Benign. ClinVar VariationId is 95520.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.928 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATP6V0A2NM_012463.4 linkc.1515T>C p.Asn505Asn splice_region_variant, synonymous_variant Exon 13 of 20 ENST00000330342.8 NP_036595.2 Q9Y487
ATP6V0A2XM_024448910.2 linkc.1515T>C p.Asn505Asn splice_region_variant, synonymous_variant Exon 13 of 19 XP_024304678.1
ATP6V0A2XM_024448911.2 linkc.1002T>C p.Asn334Asn splice_region_variant, synonymous_variant Exon 9 of 16 XP_024304679.1
ATP6V0A2XM_024448912.2 linkc.693T>C p.Asn231Asn splice_region_variant, synonymous_variant Exon 6 of 13 XP_024304680.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATP6V0A2ENST00000330342.8 linkc.1515T>C p.Asn505Asn splice_region_variant, synonymous_variant Exon 13 of 20 1 NM_012463.4 ENSP00000332247.2 Q9Y487

Frequencies

GnomAD3 genomes
AF:
0.712
AC:
108223
AN:
152036
Hom.:
39267
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.830
Gnomad AMI
AF:
0.520
Gnomad AMR
AF:
0.759
Gnomad ASJ
AF:
0.663
Gnomad EAS
AF:
0.950
Gnomad SAS
AF:
0.681
Gnomad FIN
AF:
0.681
Gnomad MID
AF:
0.621
Gnomad NFE
AF:
0.624
Gnomad OTH
AF:
0.700
GnomAD2 exomes
AF:
0.698
AC:
175478
AN:
251466
AF XY:
0.686
show subpopulations
Gnomad AFR exome
AF:
0.836
Gnomad AMR exome
AF:
0.808
Gnomad ASJ exome
AF:
0.662
Gnomad EAS exome
AF:
0.949
Gnomad FIN exome
AF:
0.674
Gnomad NFE exome
AF:
0.622
Gnomad OTH exome
AF:
0.667
GnomAD4 exome
AF:
0.645
AC:
942865
AN:
1461688
Hom.:
308278
Cov.:
54
AF XY:
0.645
AC XY:
468668
AN XY:
727168
show subpopulations
African (AFR)
AF:
0.828
AC:
27706
AN:
33474
American (AMR)
AF:
0.804
AC:
35960
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.663
AC:
17337
AN:
26134
East Asian (EAS)
AF:
0.957
AC:
37991
AN:
39696
South Asian (SAS)
AF:
0.660
AC:
56933
AN:
86256
European-Finnish (FIN)
AF:
0.677
AC:
36182
AN:
53418
Middle Eastern (MID)
AF:
0.643
AC:
3711
AN:
5768
European-Non Finnish (NFE)
AF:
0.617
AC:
686549
AN:
1111826
Other (OTH)
AF:
0.671
AC:
40496
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
20978
41957
62935
83914
104892
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18616
37232
55848
74464
93080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.712
AC:
108349
AN:
152156
Hom.:
39330
Cov.:
32
AF XY:
0.714
AC XY:
53130
AN XY:
74390
show subpopulations
African (AFR)
AF:
0.830
AC:
34451
AN:
41506
American (AMR)
AF:
0.759
AC:
11609
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.663
AC:
2299
AN:
3470
East Asian (EAS)
AF:
0.950
AC:
4923
AN:
5184
South Asian (SAS)
AF:
0.682
AC:
3290
AN:
4824
European-Finnish (FIN)
AF:
0.681
AC:
7207
AN:
10586
Middle Eastern (MID)
AF:
0.623
AC:
182
AN:
292
European-Non Finnish (NFE)
AF:
0.624
AC:
42432
AN:
67978
Other (OTH)
AF:
0.704
AC:
1483
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1578
3156
4734
6312
7890
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
828
1656
2484
3312
4140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.655
Hom.:
130258
Bravo
AF:
0.726
Asia WGS
AF:
0.831
AC:
2889
AN:
3478
EpiCase
AF:
0.622
EpiControl
AF:
0.623

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Jan 11, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 25, 2012
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cutis laxa with osteodystrophy Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Wrinkly skin syndrome Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

ALG9 congenital disorder of glycosylation Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
0.20
DANN
Benign
0.44
PhyloP100
-1.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=74/26
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000052
dbscSNV1_RF
Benign
0.018
SpliceAI score (max)
0.25
Details are displayed if max score is > 0.2
DS_AG_spliceai
0.25
Position offset: 6

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7135542; hg19: chr12-124229429; COSMIC: COSV57747649; COSMIC: COSV57747649; API